BSX•benzinga•
Boston Scientific Raises Annual Outlook After Strong Heart Devices Sales In Q1, Announces CFO Transition
Summary
Boston Scientific topped Q1 revenue and EPS forecasts, lifted its 2025 outlook, and announced CFO Dan Brennan's retirement after nearly 30 years.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 23, 2025 by benzinga